Navigation Links
AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease
Date:12/19/2007

New Alliance Seeks to Advance Understanding of Disease and Clear Path for

New Treatments

WILMINGTON, Del. and PHOENIX, Dec. 19 /PRNewswire-FirstCall/ -- The Banner Alzheimer's Institute and AstraZeneca (NYSE: AZN) today announced that they will collaborate to help advance understanding of Alzheimer's disease and increase knowledge of potential new avenues for treatment through the use of cutting-edge brain imaging methods.

The new alliance will focus on the evaluation and further development of a radioligand discovered by AstraZeneca. This radioligand is a molecule that binds to amyloid plaque -- protein deposits in the brain that are a hallmark of Alzheimer's disease -- and allows the plaque to be measured in real time using a positron emission tomography (PET) scan.

Scientists at the Banner Alzheimer's Institute and AstraZeneca hope to use this new technology to find clues to how the disease progresses and affects the brain, offering a baseline for future studies. The information could potentially be used to monitor the effectiveness of existing treatments, reveal new therapeutic targets and enhance understanding of novel ways to curtail disease progression.

"We look forward to working with AstraZeneca on the development of this promising research tool for the early detection, tracking and scientific study of Alzheimer's disease in the living human brain," said Dr. Eric Reiman, executive director of the Banner Alzheimer's Institute. "Our goals are to advance the scientific understanding of Alzheimer's disease and evaluate promising disease-slowing and prevention therapies in the most rapid and rigorous way."

Alzheimer's disease is the most common form of dementia and affect
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Pediatric Asthma Programs Featuring PARI Pharmas eFlow Acquired by AstraZeneca
2. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
3. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
4. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
5. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
6. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
7. Solazyme Selected for National Institute of Standards and Technology Award
8. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
9. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
10. National Institutes of Health Awards $25.5M Contract to SRA
11. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 A new market research ... is available from Strategic Consulting, Inc., the leading ... Microbiology Market Review, Fourth Edition: Global Review of ... tracks and compares microbiology test volumes, market values ... and Asia, and forecasts future volumes and market ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Supplementing ... offering a promotion for Eppendorf Safe Lock ... to purchase the highest quality tubes at an ... ideal for customers doing chemical, medical, pharmaceutical, and ... who are not regularly able to afford Eppendorf ...
(Date:8/27/2014)... Green & Grow Inc. (GGI) has raised an ... Otter Capital as a significant new partner. Otter Capital’s ... Agriplier™ technology, building on recent compelling field trial results ... meeting, we have been impressed with Otter Capital’s knowledge ... Sobba, President and CEO of GGI. “We look forward ...
(Date:8/27/2014)... , Aug. 27, 2014 ... report is available in its catalogue: ... http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html ... are materials that are readily decomposed by ... from conventional non-degradable packaging in terms of ...
Breaking Biology Technology:2 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7
... invention from Tel Aviv University a network of tiny ... foil even the most determined intruder. Scattered outdoors on ... of a bank, the dewdrops are a completely new and ... , Prof. Yoram Shapira and his Tel Aviv University Faculty ...
... (R) (lacosamide) C-V, a new antiepileptic drug (AED), ... week of June 2009. Vimpat was approved by ... the use as an add-on therapy for the treatment ... with epilepsy.(Photo: http://www.newscom.com/cgi-bin/prnh/20090526/NY22555 )Vimpat approval is ...
... old man with inoperable lung cancer is able to ... Surgeons told Donald Bickford, 71, that due to ... not an option for removing his lung tumor. To ... Wentworth-Douglass Hospital here, prescribed a type of non-invasive radiosurgery ...
Cached Biology Technology:Intruder alert: Tel Aviv University's 'Smart Dew' will find you! 2Vimpat(R) (lacosamide) C-V, a New Antiepileptic Drug (AED), To Be Available in U.S. Pharmacies 2Vimpat(R) (lacosamide) C-V, a New Antiepileptic Drug (AED), To Be Available in U.S. Pharmacies 3Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology 2Doctors in New Hampshire Now Treating Cancer with Non-Invasive Image-Guided Radiosurgery Using Novalis Tx(TM) Technology 3
(Date:8/28/2014)... groups and clinicians is critical to the development ... of Georgia research. , A qualitative study of ... that role models for successful breastfeeding help positively ... "Mothers who received that support are more likely ... Alex Anderson, an associate professor in the College ...
(Date:8/28/2014)... FASEB MARC (Maximizing Access to Research Careers) Program ... American College of Sports Medicine,s Conference on Integrative ... Miami, Florida. These awards are meant to ... scientists from underrepresented groups into the mainstream of ... participation of young scientists at the American College ...
(Date:8/28/2014)... roads will be built worldwide by 2050. Many of ... they bring an influx of destructive loggers, hunters and ... created a ,global roadmap, for prioritising road building across ... of development and environmental protection. , The map has ... importance of ecosystems and a ,road-benefits, layer that estimates ...
Breaking Biology News(10 mins):Breastfeeding study shows need for effective peer counseling programs 2Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3
... and Massachusetts Institute of Technology (MIT), USA, disclosed at ... the first time that targeted drug delivery is possible ... to as aptamers) are short DNA or RNA fragments ... and affinity; analogous to monoclonal antibodies. In the field ...
... therapy has been used to suppress HIV replication and ... affected patients. But the existence of viral reservoirs ... In a new study appearing on November 1 in ... from the NIH offer new insight into the eradication ...
... newest - and unequivocally the coolest - pieces of ... facility containing a state-of-the-art superconducting magnet for use in ... other proteins. , The installation of the gleaming ... a specially built facility on campus. Weighing in at ...
Cached Biology News:Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 2Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 3Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 4Superconducting magnet attracts molecular research 2
TGF-beta 2 MAb (Clone 8607)...
Abin-2 (N-16)...
... Cell Proliferation Kit, For 100 slides. ... and in vitro tissue labeling.Recommended cell ... post-labeling (labeling 1-2 hours).Store at 2-8 ... C). Category: Drug Screening & Cellular ...
Laminin beta-2 (C4)...
Biology Products: